Vir Biotechnology, Inc. VIR Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Vir Biotechnology, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s free cash flow margin?
- Vir Biotechnology, Inc. (VIR) reported free cash flow margin of -686.5% in Q1 2026.
- How has Vir Biotechnology, Inc.'s free cash flow margin changed year-over-year?
- Vir Biotechnology, Inc.'s free cash flow margin increased by 66.1% year-over-year, from -2,023.6% to -686.5%.
- What is the long-term trend for Vir Biotechnology, Inc.'s free cash flow margin?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s free cash flow margin has grown at a 17.5% compound annual growth rate (CAGR), from -258.6% to -578.5%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.